According to recent market analysis, the global qPCR reagents market is projected to grow at a compound annual growth rate (CAGR) of 7.7% in the coming years. This remarkable growth can be attributed to several key drivers, including the rising patient population base for infectious diseases and genetic disorders, coupled with the growing geriatric population and the increasing public-private investments in PCR-based research.